跳至主要内容
临床试验/ISRCTN35629189
ISRCTN35629189进行中(未招募)未知

Xpert MTB/RIF Ultra assay for the detection of Mycobacterium tuberculosis (MTB) in bronchoalveolar lavage (BAL) for pulmonary TB and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) samples for mediastinal TB

Imperial College Healthcare NHS Trust0 个研究点目标入组 646 人开始时间: 2021年2月16日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
646

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Any consenting adult =18 years of age suspected of having pulmonary TB or mediastinal TB who is undergoing a routine clinical bronchoscopy or EBUS-TBNA

排除标准

  • Any patient who has had a BAL or EBUS-TBNA but has not had Xpert Ultra testing as part of routine diagnostics for possible TB

研究者

相似试验

已完成
不适用
TB PCR in BAL and EBUS-TBNATuberculosis
NCT04909385Imperial College Healthcare NHS Trust394
招募中
不适用
Evaluation of assay kit for detecting mycoplasma infectioMycoplasma infection
JPRN-UMIN000038327Sekisui Medical Co., Ltd.200
招募中
不适用
A Novel diagnostic method using methylation of the cysteine dioxygenase 1 gene promoter DNA-Establishment of pancreatic fuluid DNA cytology test for pancreatic ductal adenocarcinomaPancreatic ductal adenocarcinoma
JPRN-UMIN000036413Department of Surgery, Kitasato University School of Medicine350
已完成
不适用
Study on rapid diagnostic reagent for Mycoplasma pneumoniae antigen detection reagent
JPRN-UMIN000032625MIZUHO MEDY Co., Ltd.150
进行中(未招募)
不适用
MINDACT (El uso de microarray en la enfermedad con ganglios negativos y de 1 a 3 ganglios positivos puede evitar la quimioterapia). Estudio prospectivo, aleatorizado que compara la firma de expresión de 70 genes de Amsterdam (firma de 70 genes) con los criterios clínico-patológicos comúnmente utilizados en la selección de pacientes con cáncer de mama de 0 a 3 ganglios positivos para quimioterapia adyuvante. (EORTC 10041 BIG 3-04)MINDACT (Microarray In Node-negative and 1 to 3 positive lymph node Disease may Avoid ChemoTherapy):A prospective, randomized study comparing the 70-gene signature with the common clinical-pathological criteria in selecting patients for adjuvant chemotherapy in breast cancer with 0 to 3 positive nodes. (EORTC 10041 BIG 3-04) - MINDACTCancer de mama de 0 a 3 ganglios linfáticos positivos.Breast cancer with 0 to 3 positive nodes.MedDRA version: 14.0Level: PTClassification code 10057654Term: Breast cancer femaleSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2005-002625-31-ESEuropean Organisation for Research and Treatment of Cancer6,000